Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 30213449

Effect of apalutamide on health-related quality of life in patients with non-metastatic castration-resistant prostate cancer: an analysis of the SPARTAN randomised, placebo-controlled, phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2018 Oct
First author
Saad F

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2018 Oct;19(10):1275-1276. doi: 10.1016/S1470-2045(18)30567-9.
    note
    Source null
    related pmid
    30213450
    relationship
    Comment in

Authors and identifiers

  1. name
    Saad F
    type
    Author
  2. name
    Cella D
    type
    Author
  3. name
    Basch E
    type
    Author
  4. name
    Hadaschik BA
    type
    Author
  5. name
    Mainwaring PN
    type
    Author
  6. name
    Oudard S
    type
    Author
  7. name
    Graff JN
    type
    Author
  8. name
    McQuarrie K
    type
    Author
  9. name
    Li S
    type
    Author
  10. name
    Hudgens S
    type
    Author
  11. name
    Lawson J
    type
    Author
  12. name
    Lopez-Gitlitz A
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Saad F
    type
    Author
  2. name
    Cella D
    type
    Author
  3. name
    Basch E
    type
    Author
  4. name
    Hadaschik BA
    type
    Author
  5. name
    Mainwaring PN
    type
    Author
  6. name
    Oudard S
    type
    Author
  7. name
    Graff JN
    type
    Author
  8. name
    McQuarrie K
    type
    Author
  9. name
    Li S
    type
    Author
  10. name
    Hudgens S
    type
    Author
  11. name
    Lawson J
    type
    Author
  12. name
    Lopez-Gitlitz A
    type
    Author
bibliography ids
  1. nci-bib-d2ea8220690e2d2ae8896e01
book metadata
content sha256
fef77b6d07e2a1bbf98e219b1a011af99fea3025bad6ecee1f6bb2c38d53a14f
document type
citation
dois
  1. 10.1016/S1470-2045(18)30456-X
electronic publication date
display
2018 Sep 10
precision
day
year
2018
evidence scope
bibliographic_metadata_only
id
pubmed:30213449
immutable id
pubmed:30213449@fef77b6d07e2a1bbf98e219b1a011af99fea3025bad6ecee1f6bb2c38d53a14f
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
10
name
The Lancet. Oncology
nlm unique id
100957246
pages
1404-1416
volume
19
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2018 Oct;19(10):1275-1276. doi: 10.1016/S1470-2045(18)30567-9.
    note
    Source null
    related pmid
    30213450
    relationship
    Comment in
outcomes validated
false
pmid
30213449
provenance
batch id
438b2803888025c6cf56
provider
NCBI PubMed ESummary
record sha256
399a8c924543aa3ab726716afc01714ce8ca337ff3c779b76530f146ccfa5c90
response sha256
0adf5ff07d3aa03a45feef5e4b7998e2ddea370eb9d1c6aa9134c5fd329767e6
retrieved at
2026-09-09T23:47:36.359220+00:00
publication date
display
2018 Oct
precision
month
year
2018
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/30213449/
title
Effect of apalutamide on health-related quality of life in patients with non-metastatic castration-resistant prostate cancer: an analysis of the SPARTAN randomised, placebo-controlled, phase 3 trial.

Preserved source evidence · Not medical advice